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went transbronchial lung cryobiopsy, and they were ran-
domly assigned to group A (4 samples obtained from the 
same segment) or group B (2 samples obtained from one 
segment and 2 samples obtained from a different segment 
of the same lobe). Analysis of the samples was performed 
sequentially (from the first to the last sample), and patholo-
gists reformulated their histopathologic diagnosis with the 
addition of each sample.  Results: The mean diagnostic yield 
of the procedure combining the 2 groups and performing 
only the first sampling was 69%. When a second biopsy was 
performed as well, the mean diagnostic yield improved, but 
this increase was significant only when the 2 samples were 
obtained from 2 different segments (96%, group B).  Conclu-
sions: This study suggests that the strategy of performing 2 
biopsies with a cryoprobe may be associated with an in-
creased diagnostic yield in diffuse parenchymal lung diseas-
es if these samples are obtained from 2 different segments 
within the same lobe.  © 2017 S. Karger AG, Basel 
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 Abstract 
 Background: Transbronchial lung cryobiopsy is an innova-
tive method of obtaining samples from the parenchyma of 
patients with diffuse parenchymal lung diseases. However, 
the technique is not yet standardized, and uncertainty exists 
about the optimal protocol, including the number of sam-
ples, the biopsy size, and the choice of the biopsy site.  Objec-
tives: To compare the diagnostic yield and complications of 
cryobiopsy with different strategies adopted to sample lung 
tissue (number of samples, biopsy site, and sample size). 
 Methods: We prospectively enrolled 46 patients with sus-
pected diffuse parenchymal lung diseases for the diagnosis 
of which a biopsy was deemed useful. All patients under-
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 Transbronchial lung cryobiopsy (TLCB) is an innova-
tive method of obtaining samples from the parenchyma 
of patients with diffuse parenchymal lung diseases 
(DPLD)  [1–4] . Support for the use of TLCB with a DPLD 
diagnosis comes from a number of recent studies and ed-
itorials  [5–15] . However, the technique is not yet stan-
dardized  [5–16] . Two to 6 biopsies are usually taken  [1, 2, 
17] , but uncertainty exists about the optimal protocol, in-
cluding the number of samples, the biopsy size, and the 
choice of the biopsy site (specifically, 1 segment only vs. 
2 segments). Non-diagnostic findings could be more 
prevalent when smaller cryobiopsy specimens are taken 
 [3] , but the exact impact of the size of specimens on the 
diagnostic yield has yet to be quantified. It is widely ac-
cepted that surgical lung biopsies (SLB) should be taken 
from 2 different lobes to minimize sampling error, but it 
is not known whether restricting the acquisition of TLCB 
to a single lobar segment reduces the diagnostic yield.
 In order to examine these questions, a prospective 
study was conducted. Our primary goal was to compare 
the diagnostic yield and the prevalence of complications 
between (a) performing all biopsies in the same lobar seg-
ment and (b) acquiring biopsies from 2 segments of the 
same lobe. We also examined the impact of increasing the 
total number of biopsies and increasing the biopsy size on 
the prevalence of non-diagnostic biopsies.
 Subjects and Methods 
 Patients with DPLD with non-diagnostic clinical profiles, CT 
scan features, and laboratory tests (including autoimmune serol-
ogy and precipitins) for whom a biopsy was deemed useful for a 
diagnosis were prospectively enrolled. Forty-six patients were en-
rolled between September 2014 and January 2015 at the Pulmonol-
ogy Unit of G.B. Morgagni – L. Pierantoni Hospital, Forlì, Italy. 
This prospective study was approved by the Area Vasta Romagna 
Ethics Committee (protocol No. 61144). Written informed con-
sent for participation in the study was obtained from each patient.
 The enrolled patients underwent TLCB and were randomly
assigned to 2 different sampling strategies: strategy A (4 samples 
obtained from the same segment [A1, A2, A3, A4]) and strategy B 
(2 samples obtained from one segment [B1, B2] and 2 samples
obtained from a different segment of the same lobe [B3, B4]).
 The following clinical data were extracted: age, gender, past 
medical history, medications, smoking history, environmental ex-
posure history, physical examination findings, laboratory results 
(including antinuclear autoantibodies, autoantibodies against ex-
tractable nuclear antigens, anti-neutrophil autoantibodies, and 
precipitins), and pulmonary function. The following were exclu-
sion criteria: (a) coagulopathy (platelet count <70,000 " 10 9 /L or 
prothrombin time international normalized ratio >1.5); (b) FVC 
<50% of the predicted value, D LCO <30% of the predicted value, 
and FEV 1 <0.8 L; (c) age <18 years; (d) diffuse bullous disease; (e) 
haemodynamic instability; (f) echocardiographic pulmonary arte-
rial systolic pressure >50 mm Hg; (g) severe hypoxaemia (Pa O 2 <50 
mm Hg on room air); and (h) a secure diagnosis based on clinical 
and high-resolution CT (HRCT) data  [18] .
 HRCT images were made within 1 month prior to bronchos-
copy. CT scans were analysed by 3 dedicated radiologists (A.C., 
S.P., and N.S.); divergent opinions were discussed and a shared 
report was provided.
 Each case was discussed during the weekly meetings in a mul-
tidisciplinary scenario with the participation of pulmonologists, 
radiologists, and pathologists. After discussion, a definite diagno-
sis was suggested; if an inability to achieve a diagnosis was recog-
nized, new investigation or follow-up was proposed.
 The patients were deeply sedated with intravenous propofol 
and remifentanil and intubated with a rigid tracheoscope (Karl 
Storz GmbH, Tuttlingen, Germany); oxygen was administered 
continuously, and spontaneous breathing was maintained during 
the procedure. A flexible cryoprobe measuring 90 cm in length 
and 2.4 mm in diameter was used (Erbokryo CA; Erbe Elektro-
medizin GmbH, Tübingen, Germany) and the probe was cooled 
with carbon dioxide (CO 2 ), which allowed the temperature in the 
probe’s tip to decrease to –75 !° !C within several seconds. Biopsies 
were obtained under fluoroscopic guidance using a flexible bron-
choscope inserted through the rigid tube into the selected bron-
chus. Particular attention was devoted to the position of the bi-
opsy; thus, biopsies taken from the same segment were taken in 
the same position (the same subsegment). Once brought into po-
sition, the probe was cooled for approximately 5 s and then re-
tracted, with the frozen lung tissue attached to the tip of the probe 
 [19] . Each biopsy was performed with a non-inflated Fogarty bal-
loon placed in the lobar bronchus; the balloon was always inflat-
ed after biopsy, then immediately deflated in the absence of 
haemorrhage. Each biopsy sample was collected and processed 
individually.
 Pathologic interpretations, made separately by experts in tho-
racic pathology (A.D., V.P., M.C., and A.C.), were based on the 
same features/criteria as used for SLB  [20] ; analysis of the samples 
was performed sequentially (from the first to the last sample), and 
the pathologists reformulated their reports with the addition of 
each sample. The samples were classified as providing a diagnostic 
pattern or not (“non-diagnostic pattern”), and divergent opinions 
were resolved by consensus. The pathologic diagnosis of usual in-
terstitial pneumonia (UIP) was made according to the criteria list-
ed in current guidelines; for the identification of a UIP pattern, the 
morphologic descriptors were patchy fibrosis, fibroblastic foci, 
and honeycombing  [10, 20–23] . Cases of UIP showing a combina-
tion of patchy fibrosis and fibroblastic foci, with or without hon-
eycombing, were assigned a rating of “high confidence” in the di-
agnosis ( Fig.!1 a); cases of “UIP with low confidence” showed the 
following: patchy fibrosis plus honeycombing (without fibroblas-
tic foci); fibroblastic foci plus honeycombing (without patchy fi-
brosis); or just 1 of the 3 main features of UIP (patchy fibrosis or 
fibroblastic foci or honeycombing) ( Fig.!1 b). All cases that exhib-
ited pathologic findings suggestive of, or definitive for, an alterna-
tive diagnosis were considered “non-UIP” and classified according 
to the characteristic pathologic features, i.e., non-specific intersti-
tial pneumonia (NSIP), organizing pneumonia, hypersensitivity 
pneumonitis, sarcoidosis, or other.
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 Statistical Analysis 
 Statistical analyses were carried out using SPSS Statistics. Data 
are reported as median and range for continuous variables, and as 
number and percentage for discrete variables. The different ap-
proaches to sampling (strategies A and B) were compared using 
standard statistical approaches (the McNemar # 2 or Fisher exact 
text for categorical variables and the Mann-Whitney U test for 
continuous variables), and a  p value of <0.05 was defined as repre-
senting a statistically significant difference.
 Results 
 Twenty-two patients underwent biopsies from the 
same segment (strategy A) and 23 patients had 2 samples 
biopsied from one segment and 2 samples from a differ-
ent segment of the same lobe (strategy B). The clinical and 
radiological features of the patients are reported in  Ta-
ble!1 . The time between introduction and removal of the 
rigid tracheoscope was 20.5 min (range 11–35) and 18 
min (range 12–27) with the 2 different sampling ap-
proaches, and no statistically significant differences were 
found. Also the time between introduction of the probe 
into the operating channel of the flexible bronchoscope 
for the first biopsy and its removal after the last biopsy 
was not statistically different between the 2 groups: 9 min 
(range 5–21) and 8.5 min (range 5–15) for group A and 
group B, respectively. All specimens except 12 (12/151 = 
8%) were considered adequate, as they contained alveo-
lated tissue. In 8 patients (18%), fewer than 4 samples 
were obtained because the resistance during retrieval of 






Cases, n 22 23
Male, n (%) 13 (59) 15 (65) 0.672
Median age (range), years 65 (79 – 29) 59 (74 – 22) 0.706
Median FVC (range), % 85.00 (137 – 49) 90.00 (122 – 55) 0.422
Median DLCO (range), % 69.00 (121 – 37) 63.00 (100 – 38) 0.361
Median BMI (range) 27.50 (32.8 – 19.8) 25.95 (33.60 – 19.00) 0.641
Possible UIP on HRCT, n (%) 10 (45) 11 (48) 0.873
Inconsistent UIP on HRCT, n (%) 12 (55) 12 (52)
TLCB, transbronchial lung cryobiopsy; UIP, usual interstitial pneumonia; HRCT, high-resolution CT.
a b
 Fig. 1. Different examples of cryobiopsy showing a usual interstitial pneumonia pattern.  a Dense scarring oblit-
erating the alveolar architecture and abruptly alternating with relatively normal areas of the lung (patchy fibrosis), 




















the probe was considered to be excessive (and potentially 
dangerous). This was also the reason for the single screen-
ing failure documented and observed in group A.
 The mean size of the samples was 29–30 mm 2 , while 
the aggregate biopsy specimen size in each single patient 
varied from 43 to 286 mm 2 (mean 95 mm 2 in group A and 
115 mm 2 in group B). The average size of the first biopsy 
was 34.58 and 37.81 mm 2 in group A and group B, respec-
tively, whereas the average size of the second biopsy was 
25.69 mm 2 (if performed in the same segment) and 28.07 
mm 2 (if performed in a different segment); there was no 
statistically significant difference in size regardless of 
whether the biopsy was performed in the same segment 
or in different segments.
 In group A, the patients underwent 4 biopsies from the 
same segment (A1, A2, A3, A4); in group B, the patients 
underwent 4 biopsies, B1 and B2 from one segment and 
B3 and B4 from a different segment. The mean diagnostic 
yield of cryobiopsy taking only 1 sample (therefore com-
bining A1 and B1) was 69% (mean rate of non-diagnostic 
appearances: 31%). Cases in which a pathologic pattern 
could be identified with only 1 sample were characterized 
by homogeneous and typical morphologic alterations 
(NSIP, organizing pneumonia, sarcoidosis, or adenocar-
cinoma). When a second biopsy was performed in the 
same segment as well (therefore combining samples A1 + 
A2 and samples B1 + B2), the mean diagnostic yield in-
creased to 78%, but with no statistically significant differ-
ence ( p = 0.340); however, if the second biopsy was taken 
from a separate segment (therefore combining samples 
B1 + B3), the diagnostic yield increased to 96% ( p = 0.004, 
McNemar # 2 test) ( Table!2 ). Furthermore, when the rela-
tionship between biopsy size and diagnostic yield was 
evaluated using simple logistic regression, there was no 
 Table 2. Diagnostic yield according to the number of samples
Group A (N = 22 patients) Group B (N = 23 patients)
Performing only 1 sample 23% not diagnostic (5/22) 39% not diagnostic (9/23)
Combining 2 samples (from the same segment) 9% not diagnostic (2/22) 35% not diagnostic (8/23)
Combining 2 samples (from different segments) 4% not diagnostic (1/23)
 Table 4. Relationship between histopathologic descriptors of the 











PF + FF + HC 1
PF + FF 2 1
Group B
UIP 5 1 4 1
PF + FF + HC 3 1 1
PF + FF + HC + ancillary 
findings of HP 0 1 1
PF + FF 2 2
UIP, usual interstitial pneumonia; PF, patchy fibrosis; FF, 
fibroblastic foci; HC, honeycombing; HP, hypersensitivity 
pneumonia.
 Table 3. Different pathologic patterns according to the different 
sampling methods used








UIP 4 11 15
NSIP 6 6
OP/NSIP 1 1 2
OP 1 2 3
Sarcoid 3 3 6




Necrotizing granuloma 1 1
DAD – fibrotic 1 1
Langerhans histiocytosis 1 1
SRIF 1 1
Bronchiolitis 1 1
Respiratory bronchiolitis 1 1
GLILD 1 1
Eosinophilic pneumonia 1 1
UIP, usual interstitial pneumonia; NSIP, non-specific 
interstitial pneumonia; OP, organizing pneumonia; DAD, diffuse 
alveolar damage; SRIF, smoking-related interstitial fibrosis; 
GLILD, granulomatous and lymphocytic interstitial lung disease.
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statistically significant relationship regardless of whether 
biopsies were performed in the same segment ( p = 0.319) 
or in different segments ( p = 0.279).
 The different pathologic patterns observed are de-
scribed in  Table!3 . The UIP pattern was identified in 15 
cases, and was more frequent in group B (different seg-
ments); all 3 morphologic descriptors of UIP were identi-
fied in 8 cases, whereas in 7 cases we identified only 2 
histopathologic descriptors of UIP: patchy fibrosis and 
fibroblastic foci  [24] ( Table!4 ). For 2 cases identified as 
“chronic hypersensitivity pneumonitis with UIP pat-
tern,” the diagnosis was obtained analysing samples ob-
tained from different segments by the presence of ancil-
lary features (foci of intra-alveolar organizing pneumo-
nia, loosely formed microgranulomas, and lymphocytic 
bronchiolitis). The NSIP pattern was detected in 8 pa-
tients ( Fig.!2 ). Each case was discussed, and a final diag-
nosis was reached; in group B, no surgical biopsy was 
deemed necessary after multidisciplinary discussion, 
whereas in group A, a surgical biopsy was performed in 2 
cases.
 Regarding safety, no severe bleeding was observed, 
only mild-to-moderate bleeding (2 cases in group A and 
2 cases in group B). Bleeding was defined as “mild” (grade 
1) if it required suction to clear but no other endoscopic 
procedures, as “moderate” (grade 2) if it required endo-
scopic procedures such as bronchial occlusion-collapse 
and/or instillation of ice-cold saline, and as “severe” 
(grade 3) if “causing haemodynamic or respiratory insta-
bility, requiring tamponade or other surgical interven-
tions, transfusions, or admission to intensive care unit” 
 [25] . Pneumothorax was documented in 16% of the cases 
(1 case in group A and 6 cases in group B) ( p = 0.096); 
fragments of pleura were found only in patients from 
whom 4 specimens were obtained (7 in group A and 6 in 
group B [13/45 = 29%]). No death, acute lung injury, per-
sistent fever, prolonged air leak, pneumonia/empyema, 
or other adverse events were observed after TLCB in the 
2 groups  [26] . When the relationship between biopsy size 
and development of complications was evaluated (pneu-
mothorax together with bleeding) by simple logistic re-
gression, there was no statistically significant relationship 
found regardless of whether biopsies were performed in 
the same segment ( p = 0.973) or in different segments
( p = 0.147).
 Discussion 
 TLCB has an increasing diagnostic value for patients 
with DPLD  [5–16] . Multiple biopsies are undertaken in 
an effort to reduce sampling error, but there are no pub-
lished studies considering the implications of such data; 
the relationship between the number of samples retrieved 
and diagnostic yield is not known, and, in particular, it is 
uncertain whether sampling from 2 segments is more 
sensitive than sampling from only 1 segment. Data on the 
different strategies adopted to sample lung tissue are still 
missing in the literature; the majority of studies reported 
retrieving lung tissue from 1 segment, and only a minor-
ity collected lung samples from different segments of the 
same lobe. No prospective studies have been published 
yet comparing these 2 approaches in terms of diagnostic 
yield and rates of complications, and no data are yet avail-
able on the diagnostic value of TLCB from 2 lobes, al-
though there are concerns about an increase in compli-
cations (mainly pneumothorax). In this first study, we 
prospectively tested the diagnostic yield of 2 different 
methods of obtaining TLCB samples from the same lobe. 
A multicentre study on diagnostic yield and complica-
tions of TLCB is ongoing, and its results may help to stan-
dardize this technique even more in the future.
 This study shows that taking 2 samples instead of only 
1 sample can increase the diagnostic yield of cryobiopsy 
in DPLD; however, this increase appears statistically sig-
nificant only when the 2 samples are taken from different 
segments. The number of NSIP patterns was higher in 
group A than in group B, whereas the UIP pattern was 
recognized at a higher rate in group B ( p < 0.05). This 
could be due to the unequal distribution of clinical cases 
 Fig. 2. Non-specific interstitial pneumonia pattern. A temporally 




















related to the small number of patients recruited. How-
ever, among those with an NSIP pattern, 1 case had a def-
inite diagnosis of idiopathic pulmonary fibrosis (IPF; af-
ter a UIP pattern had been identified in SLB samples and 
following multidisciplinary discussion), 1 case was diag-
nosed as chronic hypersensitivity pneumonitis (after hav-
ing considered the meaning of lymphocytosis in bron-
choalveolar lavage and a more precise interview), and 1 
case was classified as interstitial pneumonia with autoim-
mune features after multidisciplinary discussion of labo-
ratory, clinical, and morphologic features. These observa-
tions indicate that when a pattern of fibrosing NSIP is 
documented on cryobiopsy samples obtained from the 
same lobar segment, sampling error is a major consider-
ation, with – at least in a minority of cases – a final diag-
nosis of IPF made after multidisciplinary discussion. This 
consideration provides a strong conceptual basis for the 
practice of performing multiple biopsies in different seg-
ments.
 Regarding sample size, previous studies have report-
ed cryobiopsy samples varying in size between 9 and 
64.2 mm 2 in surface area and aggregate biopsy specimen 
sizes varying between 15 and 130 mm 2 , which is far larg-
er than the sizes of tissue samples retrieved using con-
ventional forceps  [6–15, 17] . The cryoprobes used are of 
different sizes (1.9 or 2.4 mm) and the freezing time (2–8 
s) is also different between reports in the current litera-
ture. The longer freezing times and larger diameters of 
the cryoprobes correlate positively with the weight and 
diameter of cryobiopsy samples. Concerning the depen-
dency on freezing time, a significant increase in biopsy 
weight was observed after 3 s with the 1.9-mm cryo-
probe compared with a freezing time of 2 s, and after 2 
s with the 2.4-mm probe compared with a freezing time 
of 1 s. In the studies published so far, sample sizes appear 
to be bigger when larger cryoprobes or freezing times >4 
s are used. A freezing time of 3–6 s was considered ad-
equate for larger probes (2.4 mm), while a longer freez-
ing time up to 7–8 s was considered adequate for small-
er probes  [27] .
 In our series, the 2.4-mm cryoprobe was used and was 
cooled for approximately 5 s. Furthermore, the speci-
mens obtained by cryoprobe often included structures 
from the periphery of the secondary pulmonary lobule; 
in fact, pleura was detected in 13 out of 45 cases (29%). 
Conventional transbronchial lung biopsy provides spec-
imens with these peripheral structures in less than 10% 
of cases; TLCB is able to obtain larger samples of periph-
erally located lung tissue, thereby significantly increasing 
its diagnostic yield and specificity in IPF or chronic hy-
persensitivity pneumonia, and may resolve the difficul-
ties met using conventional transbronchial lung biopsy 
 [28] . This assertion, already hypothesized in our previ-
ous study  [10] , is confirmed by the observation that the 
3 morphologic descriptors of UIP (patchy fibrosis, fibro-
blastic foci, and honeycombing) were identified in 8 cas-
es (53%), while only 2 descriptors, patchy fibrosis and 
fibroblastic foci  [24] , were identified in 7 cases (47%). 
The increased diagnostic yield of TLCB compared with 
transbronchial biopsy appears to be robust, irrespective 
of the volume of tissue acquired by TLCB. We evaluated 
the relationship between sample size and diagnostic 
yield, and we did not observe any statistically significant 
relationship regardless of whether sampling was per-
formed in the same segment or in different segments. 
Our study demonstrated a mean diagnostic yield of cryo-
biopsy of 69% (mean rate of non-diagnostic appearances: 
31%) when taking only 1 sample; when a second biopsy 
was performed as well, the mean diagnostic yield in-
creased to 78% (if the biopsy was performed in the same 
segment) or 96% (if the biopsy was performed in a sepa-
rate segment). This diagnostic yield of cryobiopsies is 
generally greater than what has previously been reported, 
varying between studies from 70–95% with a 2.4-mm 
probe to 79–80% with a 1.9-mm probe  [27] . The overall 
diagnostic yield derived from the 15 studies investigated 
in our previous meta-analysis  [29] , in which biopsies 
were taken mostly from within the same segment, was 
0.81 (0.75–0.87), which is well below the 96% observed 
in the present study.
 Transbronchial lung biopsy via cryoprobe was com-
pleted in about 20 min, compared to a reported time of 
45 min for surgical biopsy  [30] . In some patients, exces-
sive resistance during retrieval of the probe can be ob-
served. One hypothesis that could explain this phenom-
enon is that the cryoprobe is lodged in small bronchi 
(with cartilage plates in the wall) and not more distally, 
mainly due to the presence of bronchomalacia, and there-
fore the tissue (consisting mainly of the bronchial wall) 
captured by the freezing process may not be extracted 
without a strong tug. In agreement with this hypothesis is 
the fact that fragments of pleura were identified only in 
cases in which all 4 samples were taken. In this study, the 
use of smaller cryoprobes was not allowed, but this incon-
venience could be avoided (as assessed in our daily prac-
tice) using such probes (1.9 mm).
 It has recently been demonstrated that TLCB is a safe 
procedure, with lower complication and mortality rates 
compared to SLB; patient groups with DPLD undergoing 
TLCB have a significantly lower mortality rate following 
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the procedure compared to those undergoing video-
assisted thoracoscopic surgery, and the overall mortality 
rate with this procedure among approximately 1,000
patients is negligible (0.1%)  [29] . In this study, no deaths 
or acute lung injuries were observed. No severe bleeding 
occurred, and none of these patients needed an addition-
al intervention, mostly due to the preventive use of a Fog-
arty balloon, which was prophylactically placed in the lo-
bar bronchus near the biopsy segment and routinely in-
flated after sampling to minimize the consequence of 
haemorrhage. The routine preventive use of Fogarty bal-
loons was first described by our group in 2008, and it 
seems to be a very efficient way to control bleeding when 
large endoscopic lung biopsies are made  [31, 32] . More-
over, it is likely that the haemostatic effects of cooling 
contribute to the low incidence of significant bleeding 
 [29] . Pneumothorax occurred in 16% of the patients, with 
no statistically significant difference when performing bi-
opsies in different segments. We did not observe statisti-
cally significant relationships between complications and 
sample size, whether sampling in the same segment or in 
different segments.
 The study has some limitations. The number of pa-
tients enrolled was small and the identification of statisti-
cally significant group differences was difficult. Indeed, 
the significant improvement in diagnostic yield with 
2-segment sampling was demonstrable only because, by 
chance, the initial biopsy was more frequently non-diag-
nostic in group B; the improvement was nonetheless sta-
tistically significant. The absence of SLB in the vast ma-
jority of cases limited our ability to compare the accuracy 
of TLCB in terms of its sensitivity and specificity for the 
diagnosis of fibrotic DPLD. A further issue, common to 
current cryobiopsy studies, was the absence of a diagnos-
tic reference standard (a histological diagnosis by SLB). 
However, a “definitive” protocol, in which cryobiopsy is 
followed by a diagnostic surgical biopsy, raises serious 
ethical concerns. In many cases, cryobiopsy data allow the 
formulation of a definitive diagnosis, and the subsequent 
performance of a surgical biopsy merely results in avoid-
able morbidity and mortality, without any added diag-
nostic value.
 In conclusion, TLCB has a good diagnostic yield in fi-
brotic interstitial pneumonia. Pathologists are generally 
confident in their ability to make diagnoses using essen-
tially the same criteria as for SLB. In order to have a high-
er diagnostic yield in this context, 1 sample from one seg-
ment and 1 sample from a different adjacent segment 
seems to be the best strategy to follow. TLCB with a diag-
nosis of fibrotic DPLD appears safe and feasible; pneu-
mothorax is the main complication, and the preventive 
use of a Fogarty catheter might be recommended in all 
cases to prevent bleeding. The morphologic descriptors 
of complex histopathologic patterns may be identified in 
samples that are smaller than those obtained by SLB but 
significantly bigger than those collected by conventional 
transbronchial lung biopsy. Finally, in this study, at least 
21 patients (47%) had radiological features (possible UIP 
pattern on HRCT) requiring, according to the guidelines, 
an SLB  [24–26, 28–33] . TLCB allowed avoiding this inva-
sive procedure, which causes significant morbidity and 
mortality  [34–36] , in almost all of these cases  [37–39] .
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